150 related articles for article (PubMed ID: 10980240)
21. Striatal 18F-dopa uptake: absence of an aging effect.
Eidelberg D; Takikawa S; Dhawan V; Chaly T; Robeson W; Dahl R; Margouleff D; Moeller JR; Patlak CS; Fahn S
J Cereb Blood Flow Metab; 1993 Sep; 13(5):881-8. PubMed ID: 8360294
[TBL] [Abstract][Full Text] [Related]
22. Loss of metabolites from monkey striatum during PET with FDOPA.
Cumming P; Munk OL; Doudet D
Synapse; 2001 Sep; 41(3):212-8. PubMed ID: 11391782
[TBL] [Abstract][Full Text] [Related]
23. PET studies of cerebral levodopa metabolism: a review of clinical findings and modeling approaches.
Kumakura Y; Cumming P
Neuroscientist; 2009 Dec; 15(6):635-50. PubMed ID: 19793723
[TBL] [Abstract][Full Text] [Related]
24. Blood-brain transfer and metabolism of 6-[18F]fluoro-L-dopa in rat.
Reith J; Dyve S; Kuwabara H; Guttman M; Diksic M; Gjedde A
J Cereb Blood Flow Metab; 1990 Sep; 10(5):707-19. PubMed ID: 2117017
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of plasma 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine ([18F]Fdopa) in humans.
Cumming P; Léger GC; Kuwabara H; Gjedde A
J Cereb Blood Flow Metab; 1993 Jul; 13(4):668-75. PubMed ID: 8314919
[TBL] [Abstract][Full Text] [Related]
26. Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol-O-methyltransferase and monoamine oxidase type B: differing response in relation to presynaptic dopaminergic dysfunction.
Ruottinen HM; Rinne JO; Oikonen VJ; Bergman JR; Haaparanta MT; Solin OH; Ruotsalainen UH; Rinne UK
Synapse; 1997 Dec; 27(4):336-46. PubMed ID: 9372556
[TBL] [Abstract][Full Text] [Related]
27. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
Vernaleken I; Kumakura Y; Cumming P; Buchholz HG; Siessmeier T; Stoeter P; Müller MJ; Bartenstein P; Gründer G
Neuroimage; 2006 May; 30(4):1332-9. PubMed ID: 16439159
[TBL] [Abstract][Full Text] [Related]
28. PET studies of net blood-brain clearance of FDOPA to human brain: age-dependent decline of [18F]fluorodopamine storage capacity.
Kumakura Y; Vernaleken I; Gründer G; Bartenstein P; Gjedde A; Cumming P
J Cereb Blood Flow Metab; 2005 Jul; 25(7):807-19. PubMed ID: 15729292
[TBL] [Abstract][Full Text] [Related]
29. The effects of carbidopa administration on 6-[18F]fluoro-L-dopa kinetics in positron emission tomography.
Hoffman JM; Melega WP; Hawk TC; Grafton SC; Luxen A; Mahoney DK; Barrio JR; Huang SC; Mazziotta JC; Phelps ME
J Nucl Med; 1992 Aug; 33(8):1472-7. PubMed ID: 1634937
[TBL] [Abstract][Full Text] [Related]
30. Simple ratio analysis of 18F-fluorodopa uptake in striatal subregions separates patients with early Parkinson disease from healthy controls.
Jokinen P; Helenius H; Rauhala E; Brück A; Eskola O; Rinne JO
J Nucl Med; 2009 Jun; 50(6):893-9. PubMed ID: 19443601
[TBL] [Abstract][Full Text] [Related]
31. In-vivo measurement of LDOPA uptake, dopamine reserve and turnover in the rat brain using [18F]FDOPA PET.
Walker MD; Dinelle K; Kornelsen R; McCormick S; Mah C; Holden JE; Farrer MJ; Stoessl AJ; Sossi V
J Cereb Blood Flow Metab; 2013 Jan; 33(1):59-66. PubMed ID: 22929441
[TBL] [Abstract][Full Text] [Related]
32. Altered metabolism of [18F]-6-fluorodopa in the hooded rat following inhibition of catechol-O-methyltransferase with U-0521.
Cumming P; Boyes BE; Martin WR; Adam M; Ruth TJ; McGeer EG
Biochem Pharmacol; 1987 Aug; 36(15):2527-31. PubMed ID: 3111485
[TBL] [Abstract][Full Text] [Related]
33. Cerebral 6-[18F]fluoro-L-DOPA uptake in rhesus monkey: pharmacological influence of aromatic amino acid decarboxylase (AAAD) and catechol-O-methyltransferase (COMT) inhibition.
Psylla M; Günther I; Antonini A; Vontobel P; Reist HW; Zollinger A; Leenders KL
Brain Res; 1997 Aug; 767(1):45-54. PubMed ID: 9365014
[TBL] [Abstract][Full Text] [Related]
34. Human striatal L-dopa decarboxylase activity estimated in vivo using 6-[18F]fluoro-dopa and positron emission tomography: error analysis and application to normal subjects.
Kuwabara H; Cumming P; Reith J; Léger G; Diksic M; Evans AC; Gjedde A
J Cereb Blood Flow Metab; 1993 Jan; 13(1):43-56. PubMed ID: 8417009
[TBL] [Abstract][Full Text] [Related]
35. FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation.
Danielsen EH; Smith DF; Andersen F; Gee AD; Bender D; Hansen SB; Hermansen F; Østergaard L; Cumming P; Gjedde A
J Neurosci Methods; 2001 Oct; 111(2):157-68. PubMed ID: 11595282
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of striatal DOPA decarboxylase activity in Parkinson's disease.
Ishikawa T; Dhawan V; Chaly T; Margouleff C; Robeson W; Dahl JR; Mandel F; Spetsieris P; Eidelberg D
J Nucl Med; 1996 Feb; 37(2):216-22. PubMed ID: 8667047
[TBL] [Abstract][Full Text] [Related]
37. Blood-brain barrier and neuronal membrane transport of 6-[18F]fluoro-L-DOPA.
Yee RE; Cheng DW; Huang SC; Namavari M; Satyamurthy N; Barrio JR
Biochem Pharmacol; 2001 Nov; 62(10):1409-15. PubMed ID: 11709201
[TBL] [Abstract][Full Text] [Related]
38. Modeling of fluorine-18-6-fluoro-L-Dopa in humans.
Wahl L; Nahmias C
J Nucl Med; 1996 Mar; 37(3):432-7. PubMed ID: 8772639
[TBL] [Abstract][Full Text] [Related]
39. Effect of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin on in vivo L-[beta-11C]dopa turnover in the rat striatum with infusion of L-tyrosine.
Tsukada H; Lindner KJ; Hartvig P; Tani Y; Bjurling P; Kihlberg T; Westerberg G; Watanabe Y; Långström B
J Neural Transm Gen Sect; 1994; 95(1):1-15. PubMed ID: 7857582
[TBL] [Abstract][Full Text] [Related]
40. 6-[18F]fluoro-L-DOPA uptake in the rat pancreas is dependent on the tracer metabolism.
Kalliokoski T; Tuomela J; Haavisto L; Forsback S; Snellman A; Helin S; Grönroos TJ; Solin O; Haaparanta-Solin M
Mol Imaging Biol; 2014 Jun; 16(3):403-11. PubMed ID: 24217945
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
